Cargando…

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy

The aim of the study was to assess, for the first time, the prognostic role of hyponatremia and sodium normalization in patients receiving first-line chemo- or targeted therapy for advanced non-small cell lung cancer. Four hundred thirty-three patients with advanced non small cell lung cancer were t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berardi, Rossana, Santoni, Matteo, Newsom-Davis, Thomas, Caramanti, Miriam, Rinaldi, Silvia, Tiberi, Michela, Morgese, Francesca, Torniai, Mariangela, Pistelli, Mirco, Onofri, Azzurra, Bower, Marc, Cascinu, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410351/ https://www.ncbi.nlm.nih.gov/pubmed/27863417 http://dx.doi.org/10.18632/oncotarget.13372

Ejemplares similares

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
por: Berardi, Rossana, et al.
Publicado: (2020)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
por: Berardi, Rossana, et al.
Publicado: (2016)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Gender differences and outcome of melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2015)

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2017)

Gender Differences and Outcomes in Melanoma Patients
por: Morgese, Francesca, et al.
Publicado: (2020)

The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions
por: Berardi, Rossana, et al.
Publicado: (2020)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
por: Berardi, Rossana, et al.
Publicado: (2020)

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management
por: Mentrasti, Giulia, et al.
Publicado: (2020)

Systemic treatment for lung carcinoids: from bench to bedside
por: Torniai, Mariangela, et al.
Publicado: (2019)

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows
por: Torniai, Mariangela, et al.
Publicado: (2022)

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014)

High CTLA-4 expression correlates with poor prognosis in thymoma patients
por: Santoni, Giorgio, et al.
Publicado: (2018)

The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
por: Berardi, Rossana, et al.
Publicado: (2020)

Managing hyponatremia in lung cancer: latest evidence and clinical implications
por: Fiordoliva, Ilaria, et al.
Publicado: (2017)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
por: Bittoni, Alessandro, et al.
Publicado: (2015)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study
por: Fucà, Giovanni, et al.
Publicado: (2019)

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
por: Cognigni, Valeria, et al.
Publicado: (2021)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report
por: Ballatore, Z., et al.
Publicado: (2016)

Seminoma Retroperitoneal Relapse 23 Years After Surgery
por: Crocetti, Sonia, et al.
Publicado: (2021)

Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID‐ 19 pandemic
por: Agostinelli, Veronica, et al.
Publicado: (2022)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study
por: Natalucci, Valentina, et al.
Publicado: (2021)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach
por: Bittoni, Alessandro, et al.
Publicado: (2013)

A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy
por: Torresetti, Matteo, et al.
Publicado: (2020)

HIV-associated anal cancer
por: Newsom-Davis, Thomas, et al.
Publicado: (2010)

Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
por: Sigal, Samuel H., et al.
Publicado: (2018)

Intraoperative hyponatremia is an independent predictor of one-year mortality after liver transplantation
por: Yang, Seong-Mi, et al.
Publicado: (2018)

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
por: Santoni, Matteo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1kkjasscksrnrln65lgms2cvjm